| # | Drug | Count |
|---|---|---|
| 0 | PANITUMUMAB | 37 |
| 1 | BEVACIZUMAB | 32 |
| 2 | OXALIPLATIN | 24 |
| 3 | FLUOROURACIL | 23 |
| 4 | FLUOROURACIL CREAM, 0.5% | 23 |
| 5 | FRUQUINTINIB | 13 |
| 6 | REGORAFENIB | 13 |
| 7 | CAPECITABINE | 11 |
| 8 | DARATUMUMAB | 7 |
| 9 | DEXAMETHASONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 13 | 0.0033 |
| 1 | PANITUMUMAB | 37 | 0.0023 |
| 2 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 3 | REGORAFENIB | 13 | 0.0011 |
| 4 | WHITE PETROLATUM | 1 | 0.0007 |
| 5 | FLURBIPROFEN | 1 | 0.0007 |
| 6 | TRIFLURIDINE AND TIPIRACIL | 7 | 0.0006 |
| 7 | NALDEMEDINE | 1 | 0.0006 |
| 8 | SKIN PROTECTANT | 1 | 0.0004 |
| 9 | OXALIPLATIN | 24 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 38 | 0.0008 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 32 | 0.0002 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 30 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 24 | 0.0001 |
| 8 | Nucleoside Analog Antiviral [EPC] | 7 | 0.0001 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |